Litigation Details for Silbersher v. Valeant Pharmaceuticals International, Inc (N.D. Cal. 2018)

✉ Email this page to a colleague

Docket	⤷ Sign Up	Date Filed	2018-03-08
Court	District Court, N.D. California	Date Terminated	2020-07-02
Cause	31:3729 False Claims Act	Assigned To	James Donato
Jury Demand	Plaintiff	Referred To
Patents	6,551,620; 8,337,886; 8,496,965; 8,865,688
Link to Docket	External link to docket

The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2018-03-08	1	Complaint	the Otterbeck Patents. 26 4 27 The Otterbeck Patents are U.S. Patent Nos. 6,551,620 ("the …Otterbeck Patent to be approved, United States 21 Patent No. 6,551,620 ("the '620 Patent"…See e.g., U.S. Patent No. 6,551,620 at col. 5, lines 15-19. 4 70. Apriso® is a granulated…. Patent No. 8,865,688 ("the '688 Patent"). The '688 Patent was issued 3 on October… United States Patent Law 11 64. United States patents grant the patent owner or assignee	External link to document
2018-10-23	10	Amended Complaint	Otterbeck Patent to be approved, United States Patent No. 6,551,620 (“the ’620 Patent”). The ’620 Patent issued… Patent Nos. 6,551,620 (“the 7620 Patent”), 8,337,886 (“the ’886 Patent”), 8,496,965 (“the ’965 Patent….g., U.S. Patent No. 6,551,620 at col. 5, lines 15-19. 76. Apriso® is a granulated mesalamine formulation…knew that ’990 Patent, the’742 Patent, the ’858 Patent, and the “EP0169821A2 Patent patents were all in … when the Patent Office’s Patent Trial and Appeal Board (“PTAB”) invalidated the 688 Patent on the grounds	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document